WesBanco Bank’s CareDx CDNA Stock Holding History

WesBanco Bank’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-25,517	Closed	-$804K	–	521
2019 Q1	$804K	Hold	25,517	–	–	0.04%	290
2018 Q4	$641K	Sell	25,517 -21,255	-45%	-$546K	0.04%	279
2018 Q3	$1.35M	Hold	46,772	–	–	0.07%	226
2018 Q2	$572K	Buy	+46,772	New	+$536K	0.03%	333

Other funds holding CDNA

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

WesBanco Bank's CDNA Position: Q2 2019 in Review

WesBanco Bank sold out of CareDx (CDNA) in Q2 2019, closing a stake of 25,517 shares — an estimated $804K sold.

WesBanco Bank first reported a position in CDNA in Q2 2018 and held it in 4 quarters. The position peaked at $1.35M in Q3 2018. 182 funds tracked by Wall St. Rank hold CDNA as of Q2 2019.

WesBanco Bank reported no remaining CareDx position as of Q2 2019 after selling out during the quarter.
WesBanco Bank sold 25,517 CareDx shares in Q2 2019, an estimated $804K.
WesBanco Bank first reported a position in CareDx in Q2 2018 and held it in 4 quarters.
WesBanco Bank's CareDx position peaked at $1.35M in Q3 2018.
182 funds tracked by Wall St. Rank held CareDx as of Q2 2019.

Based on WesBanco Bank's 13F filing for Q2 2019, filed 13 Aug 2019.